Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Cancer-related Fatigue
Interventions
DRUG

Zhengyuan Capsules

Zhengyuan capsules, 4 capsules at a time, 3 times per day;

DRUG

Placebo contains 5%-10% Zhengyuan Capsule total mixed powder

Zhengyuan capsules simulator(Placebo contains 5%-10% Zhengyuan Capsule total mixed powder), 4 capsules at a time, 3 times per day;

All Listed Sponsors
collaborator

Yangtze River Pharmaceutical Group Co., Ltd.

INDUSTRY

lead

Qiang Fu

OTHER

NCT06381557 - Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules | Biotech Hunter | Biotech Hunter